Webinar | Asian Beauty Trends: Ingredients, Formats, and R&D signals
30th June | 12 PM ET: Register Now

Episteme Prognostics

Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.
2019
New York, New York, United States
  • Drug Discovery and Development
  • Oncology (Cancer)
  • Pathology & Diagnostics
  • Personalized Medicine Technologies

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

4.11M

Last Funding Amount

4.11M

Last Funding Date

13-04-2023

Startup Stage

Seed

People

Founders

Something missing or incorrect on this page? Help us enrich this information